Cognex Corporation CGNX | NASDAQ

$32.78 -$0.62 | -1.86%

After Hours
$33.24 $0.46 | 1.40%

Company Overview:

Market Cap: $5.57B
PE Ratio: 52.87
52-Week Range: $32.35 - $53.13
Dividend Yield (FWD): 0.98% ($0.32)

6.1 Year Performance Metrics:

Total Return (with DRIP): -23.97% (-4.39% / yr)
Total Return (no DRIP): -20.20% (-3.63% / yr)
Share Price: -27.96%
Dividend Increase: 60.00%
CGNX 6.1-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

CGNX Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
CGNX Dividend CAGR:1Y: 6.67%2Y: 6.90%5Y: 7.78%10Y: 8.62%
Share Price
CGNX Price CAGR:1Y: -17.22%2Y: -16.67%5Y: -8.26%10Y: -3.23%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

CGNX Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - CGNX
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - CGNX
14-Day FREE Trial Get Full Access Now!

CGNX Earnings, Revenue, Cash & Debt, Shares Outstaning:

CGNX - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
CGNX - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CGNX - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CGNX - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
CGNX - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
CGNX - Cash & Debt
14-Day FREE Trial Get Full Access Now!
CGNX - Revenue
14-Day FREE Trial Get Full Access Now!
CGNX Revenue CAGR:1Y: 16.79%2Y: -2.06%5Y: 6.23%10Y: 6.96%
CGNX - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
CGNX EPS CAGR:1Y: 145.78%2Y: -29.29%5Y: -19.04%10Y: 0.65%
CGNX - Net Income
14-Day FREE Trial Get Full Access Now!
CGNX Net Income CAGR:1Y: 152.44%2Y: -28.41%5Y: -18.81%10Y: 0.63%
CGNX - EBITDA
14-Day FREE Trial Get Full Access Now!
CGNX EBITDA CAGR:1Y: 82.77%2Y: -24.24%5Y: 20.20%10Y: 0.26%
CGNX - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
CGNX Free Cash Flow CAGR:1Y: 559.86%2Y: -10.94%5Y: -3.74%10Y: -4.85%
CGNX - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
CGNX Free Cash Flow / Share CAGR:1Y: 561.74%2Y: -10.59%5Y: -3.70%10Y: -4.72%
CGNX - Gross Profit
14-Day FREE Trial Get Full Access Now!
CGNX Gross Profit CAGR:1Y: 16.89%2Y: -3.51%5Y: 4.80%10Y: 6.09%
CGNX - Expenses
14-Day FREE Trial Get Full Access Now!
CGNX Expenses CAGR:1Y: -70.45%2Y: -28.56%5Y: -24.09%10Y: -16.00%
CGNX - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
CGNX Shares Outstanding CAGR:1Y: -0.04%2Y: -0.04%5Y: -0.34%10Y: -0.30%
CGNX - Share Buybacks
14-Day FREE Trial Get Full Access Now!
CGNX Share Buybacks CAGR:1Y: 114.57%2Y: 29.15%5Y: N/A10Y: 5.83%
CGNX - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
CGNX Stock-Based Comp CAGR:1Y: -1.31%2Y: -0.04%5Y: 1.48%10Y: 12.86%
CGNX - Dividends
14-Day FREE Trial Get Full Access Now!
CGNX Dividend CAGR:1Y: 6.67%2Y: 6.90%5Y: 7.78%10Y: 8.62%
CGNX - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
CGNX Revenue CAGR:1Y: 16.79%2Y: -2.06%5Y: 6.23%10Y: 6.96%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

CGNX - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CGNX Actual Revenue CAGR:1Y: 16.79%2Y: -2.06%5Y: 6.23%10Y: 6.96%
CGNX - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CGNX Actual EPS CAGR:1Y: 145.78%2Y: -29.29%5Y: -19.04%10Y: 0.65%
CGNX - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CGNX Actual Net Income CAGR:1Y: 152.44%2Y: -28.41%5Y: -18.81%10Y: 0.63%
CGNX - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CGNX Actual EBITDA CAGR:1Y: 82.77%2Y: -24.24%5Y: 20.20%10Y: 0.26%

Ratios, Profit Margins & Return on Capital:

CGNX - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
CGNX Net Profit Margin CAGR:1Y: 116.11%2Y: -26.91%5Y: -23.57%10Y: -5.93%
CGNX - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
CGNX Gross Profit Margin CAGR:1Y: 0.09%2Y: -1.49%5Y: -1.35%10Y: -0.81%
CGNX - Price to Earnings
14-Day FREE Trial Get Full Access Now!
CGNX - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
CGNX - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
CGNX - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

CGNX Dividends Info:

Annual Dividend: $0.32
Forward Yield: 0.98%
Ex-Dividend Date: 2025-02-27
Lifetime Dividens / Share: $5.29

CGNX Dividend History: Dates, Payments & Yield list

Below is a schedule of all CGNX dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
02/27/202503/13/2025$0.0800.95%0.98%$32.78
11/14/202411/29/2024$0.0800.75%0.79%$40.53
08/15/202408/29/2024$0.0750.76%0.76%$39.34
05/15/202405/30/2024$0.0750.62%0.63%$47.44
02/28/202403/14/2024$0.0750.76%0.79%$38.16
11/16/202312/01/2023$0.0750.78%0.82%$36.57
08/17/202309/01/2023$0.0700.6%0.6%$46.43
05/18/202306/02/2023$0.0700.53%0.54%$52.20
03/02/202303/17/2023$0.0700.57%0.59%$47.78
11/17/202212/02/2022$0.0700.54%0.57%$48.91
08/18/202209/02/2022$0.0650.55%0.55%$47.21
05/19/202206/03/2022$0.0650.54%0.55%$47.32
03/03/202203/18/2022$0.0650.38%0.39%$66.67
11/18/202112/03/2021$0.0650.31%0.33%$79.33
08/19/202109/03/2021$0.0602.61%0.29%$83.56
05/20/202106/04/2021$0.0602.83%0.31%$77.02
02/25/202103/12/2021$0.0602.67%0.29%$81.42
12/11/202012/28/2020$2.0002.83%10.44%$76.65
11/12/202011/27/2020$0.0600.32%0.34%$70.07
08/13/202008/28/2020$0.0550.32%0.32%$67.87
05/14/202005/29/2020$0.0550.38%0.39%$56.23
02/27/202003/13/2020$0.0550.47%0.49%$44.56
11/14/201911/29/2019$0.0550.4%0.43%$50.86
08/15/201908/30/2019$0.0500.46%0.46%$43.52
05/16/201905/31/2019$0.0500.43%0.45%$44.94
02/28/201903/15/2019$0.0500.36%0.37%$53.40
11/15/201811/30/2018$0.0500%0%$0.00
08/16/201808/31/2018$0.0450%0%$0.00
05/17/201806/01/2018$0.0450%0%$0.00
03/01/201803/16/2018$0.0450%0%$0.00
11/16/201712/01/2017$0.0450%0%$0.00
08/16/201709/01/2017$0.0430%0%$0.00
05/31/201706/16/2017$0.0430%0%$0.00
03/01/201703/17/2017$0.0380%0%$0.00
11/30/201612/16/2016$0.0380%0%$0.00
08/31/201609/16/2016$0.0380%0%$0.00
06/01/201606/17/2016$0.0380%0%$0.00
03/02/201603/18/2016$0.0350%0%$0.00
12/02/201512/18/2015$0.0350%0%$0.00
09/02/201509/18/2015$0.0350%0%$0.00
06/03/201506/19/2015$0.0350%0%$0.00
12/12/201212/24/2012$0.2780%0%$0.00
11/28/201212/14/2012$0.0280%0%$0.00
08/29/201209/14/2012$0.0280%0%$0.00
05/30/201206/15/2012$0.0280%0%$0.00
02/29/201203/16/2012$0.0250%0%$0.00
11/30/201112/16/2011$0.0250%0%$0.00
08/31/201109/16/2011$0.0230%0%$0.00
06/01/201106/17/2011$0.0230%0%$0.00
03/02/201103/18/2011$0.0200%0%$0.00
12/01/201012/17/2010$0.0200%0%$0.00
09/01/201009/17/2010$0.0150%0%$0.00
06/02/201006/18/2010$0.0150%0%$0.00
03/03/201003/19/2010$0.0130%0%$0.00
12/02/200912/18/2009$0.0130%0%$0.00
09/02/200909/18/2009$0.0130%0%$0.00
06/03/200906/19/2009$0.0130%0%$0.00
03/04/200903/20/2009$0.0380%0%$0.00
11/25/200812/12/2008$0.0380%0%$0.00
08/27/200809/12/2008$0.0380%0%$0.00
05/28/200806/13/2008$0.0210%0%$0.00
02/27/200803/14/2008$0.0210%0%$0.00
11/14/200711/30/2007$0.0210%0%$0.00
08/08/200708/24/2007$0.0210%0%$0.00
05/09/200705/25/2007$0.0210%0%$0.00
02/07/200702/23/2007$0.0210%0%$0.00
11/08/200611/24/2006$0.0210%0%$0.00
08/09/200608/25/2006$0.0210%0%$0.00
05/10/200605/26/2006$0.0200%0%$0.00
02/08/200602/24/2006$0.0200%0%$0.00
11/08/200511/25/2005$0.0200%0%$0.00
08/03/200508/19/2005$0.0200%0%$0.00
05/04/200505/20/2005$0.0200%0%$0.00
02/09/200502/25/2005$0.0200%0%$0.00
11/03/200411/19/2004$0.0200%0%$0.00
08/04/200408/20/2004$0.0200%0%$0.00
05/05/200405/21/2004$0.0150%0%$0.00
02/18/200403/05/2004$0.0150%0%$0.00
11/06/200311/25/2003$0.0150%0%$0.00
08/27/200309/19/2003$0.0150%0%$0.00

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for CGNX

Based on past 6.1-year performance, here are CGNX growth metrics:

Share price CAGR of -7.35%
Dividend CAGR of +8.62%
Using CGNX CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

CGNX
Current Price$32.78
Start Shares305.06
Start Value$10,000
 
After 10 years:
Final Share Count380.30
Dividends Payment$0.18
Annual Dividends$278
Yield on cost2.78%
Share Price$16.49
Total Dividends$1,603
Final Value$6,270

Estimated Future Value + Dividends - CGNX

NOTE: Above numbers are our estimate based on CGNX's Dividend and Price CAGR over past 6.1 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Cognex Corporation (CGNX) had its IPO on 1989-07-20, and is trader on NASDAQ stock exchange.

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. Cognex Corporation was incorporated in 1981 and is headquartered in Natick, Massachusetts.

CGNX website: https://www.cognex.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial